• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
    • Cell & Gene Therapy
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Images of two chess pieces right in front of each other
Biotech

Novo, Pfizer bidding war for Metsera heats up with larger offers

In total, Pfizer is now willing to part with around $8.1 billion for Metsera. But Novo is offering even more.
James Waldron Nov 4, 2025 10:18am
Syneos HealthOvarian Cancer Trials 16x9v2png
Sponsored

Protocol-Ready Doesn’t Mean Trial-Ready in Ovarian Cancer Clinical Trials

Nov 3, 2025 8:00am
Purple cartoon graveyard with castle in the back and giant full moon

The 2025 Biotech Graveyard

Oct 31, 2025 5:00am
How do you get pharmaceutical treatments where theyre needed most
Sponsored

How to get pharmaceutical treatments where they’re needed most.

Oct 6, 2025 8:00am
cartoon of man unplugging from outlet

Pfizer pulls the plug on 11 programs

Nov 4, 2025 2:40pm
Red light traffic

Harmony halts genetic disease program after ph. 3 failure

Nov 4, 2025 12:45pm
More News

Publisher’s note: Questex acquires The Conference Forum, Versalinx

Nov 4, 2025 12:00pm
Fierce Healthcare

Government shutdown updates: Plan to extend, reform tax credits

Nov 4, 2025 11:30am

Prelude loses CMO, pauses SMARCA2 degraders, scores Incyte cash

Nov 4, 2025 9:40am

Merck bags $700M from Blackstone, spends $150M to regain asset

Nov 4, 2025 9:15am
See more stories
Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings